Alpramil 12 mg/30 mg film-coated tablets for cats weighing at least 3 kg
Alpramil 12 mg/30 mg film-coated tablets for cats weighing at least 3 kg
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
Alpramil 12 mg/30 mg film-coated tablets for cats weighing at least 3 kg
Alpramil 12 mg/30 mg филмирани таблетки за котки с тегло най-малко 3 kg
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime12.00milligram(s)1.00Tablet
-
Praziquantel30.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Package description:
- Box with 10 PVC / PE / PVDC - Aluminium blisters each containing 1 tablet.
- Box with 1 PVC / PE / PVDC - Aluminium blister containing 4 tablets.
- Box with 25 PVC / PE / PVDC - Aluminium blisters each containing 4 tablets.
- Box with 25 PVC / PE / PVDC - Aluminium blisters each containing 2 tablets.
- Box with 25 PVC / PE / PVDC - Aluminium blisters each containing 1 tablet.
- Box with 10 PVC / PE / PVDC - Aluminium blisters each containing 4 tablets.
- Box with 10 PVC / PE / PVDC - Aluminium blisters each containing 2 tablets.
- Box with 1 PVC/PE/PVDC - Aluminium blister containing 2 tablets.
- Box with 1 PVC/PE/PVDC - Aluminium blister containing 1 tablet.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan Nederland B.V.
- Lelypharma B.V.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-3147
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0364/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 12/05/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 15/07/2024
NL_V_0364_001-003_DC Alpramil film-coated tablets for cats- Final PuAR.pdf
English (PDF)
Download Published on: 29/02/2024
How useful was this page?: